VitalSigns
Return to the Blog Homepage

Tag Archives: healthcare communications

The Week That Was: Crises in Healthcare Communications

Patients Paying Premiums Getting a Whole Lot of Nothing? Last week, patients and biopharmas alike got support from an unlikely ally in the battle for access to specialty medicines. The New York State Attorney General’s office issued subpoenas to 16...

The Week That Was: Crises in Healthcare Communications

SEAWORLD STAFF SPIES ON SHAMU SUPPORTERS Have you ever been bored on a weekend and asked yourself, “I know, why don’t I go impersonate an animal rights activist on behalf of my employer who trains large mammals in captivity… and...

The Week That Was: Crises in Healthcare Communications

GOGO NOW A “NO-GO” AT AMERICAN AIRLINES Wifi is the most sought after feature on a flight, which is why American Airlines is seeking to end its contract with wireless Internet provider Gogo. The airline filed a lawsuit with the...

The Week That Was: Crises in Healthcare Communications

SUPER BOWL ADS GET TACKLED Denver Broncos or Carolina Panthers? For many Americans, the winner of the big game was inconsequential compared to the commercials that aired. Considering the hype around Super Bowl advertisements, it seems inevitable that at least...

The Week That Was: Crises in Healthcare Communications

  CONGRESS FIRES AT PHARMA The day we’ve all been waiting for did not disappoint. In fact, the rhetoric was fiery between Congressional committee members and pharmaceutical executives testifying at Thursday’s hearing on drug pricing. Convened by the Congressional Committee...

February 2, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: ,

The Week That Was: Crises in Healthcare Communications

COMPOUNDING PHARMA THE MOST TRUSTED VOICE IN HEALTH? “When pigs fly.” That would’ve been our response if you had asked us a year ago the likelihood that a compounding pharmacy would be among the most trusted voices in healthcare. But,...

The Week That Was: Crises in Healthcare Communications

Are Drug Companies Getting More for the Money? Are drug companies getting more for the money they contribute to patient advocacy groups? Yes, they’re buying silence in the debate on high drug pricing, according to the former Chief of Biotechnics...

July 1, 2015

0 Comments

Written by

Categories: Communications, Health

Tags: ,

Adapt or Die: What it Takes to Survive in Pharma

Charles Darwin once said, “It is not the strongest of the species that survive, nor the most intelligent, but the one more responsive to change.” This observation is brilliant in its simplicity. It speaks to the underlying primal need we...